Vaccine advisers to the FDA decided Thursday that only strains of the JN.1 variant should be targeted by updated versions of covid vaccines that will be available next fall and winter. Separately, ...

The agreement between BioNTech’s subsidiary BioNTech UK and the UK government is focused on accelerating clinical trials for ...

Biopharmaceutical company BioNTech has announced funding of up to £1 billion into the United Kingdom over the next 10 years.

The UK will offer a vaccine originally intended to prevent meningitis, which is caused by a bacteria with a similar genetic profile to the one that causes gonorrhoea. View on euronews ...

A £129 million government grant will help the firm establish new R&D centers for advancing new cancer immunotherapies including personalized mRNA vaccines.

BioNTech will invest up to £1bn in UK life sciences over 10 years, launching new AI and R&D centres in London and Cambridge.

Hundreds of highly skilled jobs will be created, and new research centres will be set up aimed at making new advances in ...

German vaccine maker BioNTech SE (NASDAQ:BNTX) revealed on May 20 that it intends to boost its presence in the UK with an investment of up to £1 billion ($1.33 billion) over the next decade, focusing ...

As well as the economic and employment benefits, BioNTech’s UK investment is expected to deliver tangible improvements in healthcare. The company’s work in personalised cancer immunotherapies, already ...

Government signs deal to see huge investment in mRNA vaccine manufacturing which could help tackle the next pandemic and ...

Sir Keir Starmer pledged that his trade deal with the EU would ‘cut the price of the weekly shop’ and provide stability for the fishing industry ...

The change marks a shift in the Food and Drug Administration’s policy on approving COVID-19 vaccines, which the new ...